Skip NavigationSkip to Content

Caspase-mediated apoptosis and caspase-independent cell death induced by irofulven in prostate cancer cells

  1. Author:
    Liang, H. Y.
    Salinas, R. A.
    Leal, B. Z.
    Kosakowska-Cholody, T.
    Michejda, C. J.
    Waters, S. J.
    Herman, T. S.
    Woynarowski, J. M.
    Woynarowska, B. A.
  2. Author Address

    Univ Texas, Hlth Sci Ctr, Dept Radiat Oncol, San Antonio, TX 78245 USA. Natl Canc Inst, Frederick, MD USA. MGI Pharma Inc, Bloomington, MN USA Woynarowski, JM, Univ Texas, Hlth Sci Ctr, Dept Radiat Oncol, 1DD Bldg,14960 Omicron Dr, San Antonio, TX 78245 USA
    1. Year: 2004
    2. Date: NOV
  1. Journal: Molecular Cancer Therapeutics
    1. 3
    2. 11
    3. Pages: 1385-1396
  2. Type of Article: Article
  1. Abstract:

    lrofulven (hydroxymethylacylfulvene) is a novel antitumor drug, which acts by alkylating cellular macromolecular targets. The drug is a potent inducer of apoptosis in various types of tumor cells, whereas it is nonapoptotic in normal cells. This study defined molecular responses to irofulven involving mitochondrial dysfunction and leading to death of prostate tumor LNCaP-Pro5 cells. lrofulven caused early (2-5 hours) translocation of the proapoptotic Bax from cytosol to mitochondria followed by the dissipation of mitochondrial membrane potential and cytochrome c release at 4 to 12 hours. These effects preceded caspase activation and during the first 6 hours were not affected by caspase inhibitors. Processing of caspase-9 initiated the caspase cascade at similar to6 hours and progressed over time. The activation of the caspase cascade provided a positive feedback loop that enhanced Bcl-2-independent translocation and cytochrome c release. General and specific caspase inhibitors abrogated irofulven-induced apoptotic DNA fragmentation with the following order of potency: pan-caspase greater than or equal to caspase-9 > caspase-8/6 > caspase-2 > caspase-3/7 > caspase-1/4. Abrogation of caspase-mediated DNA fragmentation failed to salvage irofulventreated cells from growth inhibition and loss of viability, demonstrating a substantial contribution of a caspase-independent cell death. Monobromobimane, an inhibitor of alternative caspase-independent apoptotic pathway that is mediated by mitochondrial permeability transition, antagonized both apoptosis, measured as phosphatidylserine externalization, and cytotoxicity of irofulven. Collectively, the results indicate that irofulven-induced signaling is integrated at the level of mitochondrial dysfunction. The induction of both caspase-dependent and caspase-independent death pathways is consistent with pleiotropic effects of irofulven, which include targeting of cellular DNA and. proteins

    See More

External Sources

  1. WOS: 000225070800005

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel